Theodore Karrison

University of Chicago

Papers

2

Total Citations

92

H-Index

2

About

Theodore Karrison is a leading biostatistician whose work has profoundly shaped clinical research in urologic oncology and beyond. His key research areas include the design and analysis of randomized clinical trials, survival analysis, and the application of rigorous statistical methods to evaluate surgical outcomes. Karrison’s major contributions lie in providing the quantitative backbone for landmark studies comparing surgical techniques, most notably in prostate cancer. He was instrumental in a pivotal 2016 study (59 citations) comparing perioperative and oncologic outcomes between open and robotic-assisted laparoscopic prostatectomy, using a large population-based cohort to clarify real-world surgical effectiveness. He also led the statistical design of a 2014 randomized trial (33 citations) that evaluated early urethral catheter removal with suprapubic tube drainage, directly improving postoperative recovery protocols. Beyond these highly cited works, Karrison is renowned for his methodological expertise in handling complex data and ensuring the integrity of clinical trials. His impact is measured not only in citation counts but in the countless surgeons and researchers who rely on his analytical frameworks to make evidence-based decisions, cementing his reputation as a trusted architect of modern clinical biostatistics.

Research Focus

Key Achievements

2
H-Index
2
Papers
92
Total Citations
46
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Perioperative and Early Oncologic Outcomes between Open and Robotic Assisted Laparoscopic Prostatectomy in a Contemporary Population Based Cohort
59 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: University of Chicago

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago